The HTS Facility is a state-of-the-art technological hub that performs HTS of chemical and natural product libraries, including new fragment-based libraries (associated with the NMR Core Facility) and, ultimately, miRNA libraries.
Recent advances in mass spectrometry instrumentation and data analysis have revolutionized the way proteins are identified and quantified in biomedical research. Mass Spectrometry Laboratory offers a wide spectrum of proteomics analysis including 1-D and 2-D electrophoresis, in-gel digestion, robotic gel spot excision, protein identification, sequence characterization of peptides, identification of post-translational modification sites
The Structural Biology Core Laboratory has state-of-the-art instrumentation and expert staff to enable detailed structural and biophysical studies of biological macromolecules in human health and disease. Our capabilities include X-ray crystallography, NMR spectroscopy and a new Cryo-EM facility for single particle analysis and structure determination in addition to resources and infrastructure to assist users with protein production and characterization.
The Center for Innovative Drug Discovery (CIDD) is a joint venture between University of Texas Health San Antonio (UTHSA) and University of Texas at San Antonio (UTSA) and co-directed by Dr. Daohong Zhou and Dr. Stanton McHardy. It provides a diverse array of core facilities and expertise to facilitate the translation of basic scientific discoveries into pre-clinical drug candidates that can be further developed into therapeutics for human diseases.